Growth Metrics

Boston Scientific (BSX) Total Non-Current Liabilities (2016 - 2025)

Boston Scientific's Total Non-Current Liabilities history spans 16 years, with the latest figure at $17.0 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 9.75% year-over-year to $17.0 billion; the TTM value through Dec 2025 reached $17.0 billion, up 9.75%, while the annual FY2025 figure was $17.0 billion, 9.75% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $17.0 billion at Boston Scientific, up from -$403.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $38.2 billion in Q1 2025 and bottomed at -$22.0 billion in Q2 2021.
  • The 5-year median for Total Non-Current Liabilities is $15.2 billion (2023), against an average of $10.7 billion.
  • The largest annual shift saw Total Non-Current Liabilities tumbled 2379.16% in 2022 before it soared 68353.57% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $31.7 billion in 2021, then grew by 8.01% to $34.3 billion in 2022, then tumbled by 55.66% to $15.2 billion in 2023, then rose by 2.1% to $15.5 billion in 2024, then increased by 9.75% to $17.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Total Non-Current Liabilities are $17.0 billion (Q4 2025), -$403.0 million (Q3 2025), and $19.6 billion (Q2 2025).